Arc Ventures is a New York-based venture capital firm founded in 2014 by Joe Korff. The firm invests in early-stage to growth-stage founders and fund managers across software, deep tech, and health sciences, backing over 50 founders from seed to growth stages.
Their most common stage is seed (50% of deals). Average disclosed round size is $48.8M (across 9 rounds with reported amounts).
Portfolio
9
Fund Size
—
Top Stage
Seed
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 BQP | Seed | $5M | Jul 2025 |
| EExsilio Therapeutics | Series A | $82M | Jun 2024 |
| AAverna Therapeutics | Series A | $82M | Jan 2024 |
 Avernatx | Series A | $82M | Jan 2024 |
| AAverna | Series A | $82M | Jan 2024 |
| EExsilio Therapeutics | Series A | $82M | Jan 2024 |
 Tanda | Seed | $4.5M | Nov 2023 |
 Surein | Seed | — | Aug 2023 |
 Nirvana Health | Seed | $7.5M | Nov 2021 |
 Niv-AI | Seed | $12M | — |
Top Co-Investors
Innovation Endeavors5 shared
Delos Capital5 shared
OrbiMed5 shared
Deep Insight5 shared
Insight Partners5 shared
The Invus Group, LLC5 shared
Novartis Venture Fund3 shared
Initialized Capital1 shared
Arc1 shared
Armory Square Ventures1 shared
Emergent Ventures1 shared
Alumni Ventures1 shared
Monta Vista Capital1 shared
Union Square Ventures1 shared
India Quotient1 shared
Transpose Platform1 shared
Gaingels1 shared
Arka Venture Labs1 shared
New York Ventures1 shared
Last updated: 20 October 2026